It is one of the highest honours in the Canadian health sciences community — and now it’s another line on the impressive resumé of Dr. Bernard Le Foll, Waypoint’s Vice-President of Research and Academics.
The Canadian Academy of Health Sciences (CAHS) has elected Dr. Le Foll as a fellow for 2025, recognizing his commitment to serve the academy and advance research across all disciplines
I’m truly honoured to be named a fellow of the Canadian Academy of Health Sciences. This recognition is a reflection of the hard work and support from so many colleagues along the way. I’m excited to join such a talented group and to help advance health sciences in ways that make a real difference.
Dr. Bernard Le Foll, Vice-President, Research and Academics and Chief Scientific Officer
The CAHS announced 47 new fellows on Aug. 19, reflecting a rich and varied expertise. The fellows, who serve as unpaid volunteers, are nominated by their institutions and peers and selected in a competitive process based on their internationally recognized leadership, academic performance, scientific creativity and willingness to serve.
“We congratulate all the applicants elected as fellows to the Canadian Academy of Health Sciences for 2025. This recognition honours their dedication and excellence in their respective fields,” said Dr. Sylvie Nadeau, Chair of the Fellowship Committee. “We look forward to their expertise enriching the work of our academy.”
Dr. Le Foll earned his PhD in Pharmacology from the University of Paris-Sud, and trained at the National Institutes of Health in behavioral pharmacology and brain imaging. He joined the Waypoint senior leadership team in February 2022. A clinician-scientist specializing in drug addiction, Dr. Le Foll’s research focuses on addiction neurobiology and therapies. He has received many awards and more than 100 grants, and has published more than 300 peer-reviewed scientific articles. He has held various leadership roles at the Centre for Addiction and Mental Health, advised on addiction policy, and serves on the Canadian Institutes of Health Research governing council.